Shares of Second Sight Medical Products Inc (EYES) stock jumped nearly 24% Wednesday and are up more than 40% over the past 30 days. EYES stock has fallen -38.51% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives EYES stock a score of 76 out of a possible 100.
That score is primarily influenced by a fundamental score of 91. In addition to the average rating from Wall Street analysts, EYES stock has a mean target price of $2.50. This means analysts expect the stock to rise 133.64% over the next 12 months. EYES’s score also includes a short-term technical score of 79. The long-term technical score for EYES is 58.
What’s Happening with EYES Stock Today
Second Sight Medical Products Inc (EYES) stock is lower by -6.14% while the S&P 500 is up 0.14% as of 11:05 AM on Thursday, Apr 11. EYES has fallen -$0.07 from the previous closing price of $1.14 on volume of 471,132 shares. Over the past year the S&P 500 is up 8.86% while EYES has fallen -38.51%. EYES lost -$0.53 per share in the over the last 12 months.